Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,481.00
-33.10 (-1.32%)
May 22, 2026, 3:30 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.02 trillion as of May 22, 2026. Its market cap has increased by 2.71% in one year.
Market Cap
1.02T
Enterprise Value
1.07T
Revenue
142.78B
Ranking
n/a
PE Ratio
53.57
Stock Price
2,481.00
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.02T, an increase of 79.65%. That is a compound annual growth rate of 21.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.02T | 12.89% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.83T |
| Cipla | 1.13T |
| Zydus Lifesciences | 1.05T |
| Aurobindo Pharma | 850.00B |
| Laurus Labs | 725.30B |
| Alkem Laboratories | 657.79B |
| Glenmark Pharmaceuticals | 637.52B |
| Ipca Laboratories | 406.46B |